Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,699,363 papers from all fields of science
Search
Sign In
Create Free Account
SERPINB12 gene
Known as:
SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 12
, SERPINB12
, serpin family B member 12
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SERPINB11 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Sa1295 – Serpinb12 As a Possible Marker of Steroid Dependency in Children with Eosinophilic Esophagitis: A Pilot Study
S. Oliva
,
C. Carissimi
,
+5 authors
L. Stronati
Gastroenterology
2019
Corpus ID: 164346835
2018
2018
Schlafen12 interaction with SerpinB12 and deubiquitylases drives human enterocyte differentiation Condensed title: SLFN12 regulation of enterocyte differentiation
M. Basson
,
Qinggang Wang
,
+7 authors
M. Kiupel
2018
Corpus ID: 51901466
Background/Aims: Human enterocytic differentiation is altered during development, fasting, adaptation, and bariatric surgery, but…
Expand
Review
2015
Review
2015
Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases.
Rami A. Al‐Horani
Cardiovascular & Hematological Agents in…
2015
Corpus ID: 6383037
Fibrinolysis is the ultimate outcome of a cascade of enzymatic reactions in which serine proteases such as plasmin, tissue…
Expand
2014
2014
Avian SERPINB12 Expression in the Avian Oviduct Is Regulated by Estrogen and Up-Regulated in Epithelial Cell-Derived Ovarian Carcinomas of Laying Hens
Gahee Jo
,
W. Lim
,
Seung-Min Bae
,
F. Bazer
,
G. Song
PLoS ONE
2014
Corpus ID: 6619390
Serine protease inhibitors (SERPINs) are involved in a variety of biological processes such as blood clotting, angiogenesis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE